Aegerion Pharmaceuticals, Inc. (AEGR) said Monday that Marc Beer offered his resignation as CEO and member of the board, as did Craig Fraser as Chief Operating Officer, effective immediately.
Board member Sandford Drexel Smith has been appointed interim Chief Executive Officer, while the company conducts a search to identify a successor, Aegerion said. Smith will also assume Fraser's responsibilities on an interim basis.
Smith has served as a director of Aegerion since 2012 and was most recently Executive Vice President and President International Group for Genzyme Corp.
Aegerion also reported preliminary second quarter total net product sales of $63 million to $64 million.
Analysts polled by Thomson Reuters currently expect the company to post revenue of $56.94 million for the second quarter.
The company will announce second quarter financial results on August 5.
For comments and feedback contact: editorial@rttnews.com
Business News